Your browser doesn't support javascript.
loading
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium.
Leal, Teresinha; Bergamini, Gabriella; Huaux, François; Panin, Nadtha; Noel, Sabrina; Dhooghe, Barbara; Haaf, Jeremy B; Mauri, Pierluigi; Motta, Sara; Di Silvestre, Dario; Melotti, Paola; Sorio, Claudio.
Afiliação
  • Leal T; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain , Brussels , Belgium.
  • Bergamini G; Cystic Fibrosis Translational Research Laboratory "D. Lissandrini", Department of Medicine, Division of General Pathology, University of Verona, Verona, Italy; Cystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
  • Huaux F; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain , Brussels , Belgium.
  • Panin N; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain , Brussels , Belgium.
  • Noel S; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain , Brussels , Belgium.
  • Dhooghe B; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain , Brussels , Belgium.
  • Haaf JB; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain , Brussels , Belgium.
  • Mauri P; Institute for Biomedical Technologies (ITB-CNR), Segrate , Milan , Italy.
  • Motta S; Institute for Biomedical Technologies (ITB-CNR), Segrate , Milan , Italy.
  • Di Silvestre D; Institute for Biomedical Technologies (ITB-CNR), Segrate , Milan , Italy.
  • Melotti P; Cystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata di Verona , Verona , Italy.
  • Sorio C; Cystic Fibrosis Translational Research Laboratory "D. Lissandrini", Department of Medicine, Division of General Pathology, University of Verona , Verona , Italy.
Front Immunol ; 7: 499, 2016.
Article em En | MEDLINE | ID: mdl-27895643
BACKGROUND: Pseudomonas aeruginosa airway infections are a major cause of morbidity and mortality in patients with cystic fibrosis (CF). Azithromycin improves the related clinical outcomes, but its mechanisms of action remain poorly understood. We tested the hypothesis that azithromycin downregulates P. aeruginosa-induced pro-inflammatory responses by modifying release of bacterial proteins. METHODS: We monitored inflammatory markers in lungs of CF mutant mice and their littermate controls in response to conditioned media (CM) collected from the reference P. aeruginosa PAO1 strain cultured in the presence or in the absence of azithromycin. A mass spectrometry-based proteomic approach was applied to examine whether the macrolide elicits a differential release of bacterial proteins. RESULTS: CM collected from azithromycin-untreated PAO1 cultures induced powerful pro-inflammatory neutrophil-dominated responses. Azithromycin attenuated the responses, mainly of macrophage chemoattractant protein-1, tumor necrosis factor-α, and interferon-γ, in CF but not in wild-type mice. Proteomic analysis showed that azithromycin upregulated an array of bacterial proteins including those associated with regulation of immune functions and with repair and resolution of inflammatory responses like the chaperone DnaK and the S-adenosylmethionine synthase, while it downregulated the extracellular heme acquisition protein HasA and the catalytic enzyme lysylendopeptidase. CONCLUSION: Supernatants collected from cultures of the bacterial strain PAO1 represent a novel experimental model to trigger in vivo lung inflammatory responses that should be closer to those obtained with live bacteria, but without bacterial infection. Combined with a bactericidal effect, complex regulation of bacterial innate immune and metabolic factors released in the cultured medium by the action of the macrolide can contribute to its anti-inflammatory effects.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Immunol Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Immunol Ano de publicação: 2016 Tipo de documento: Article